U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07840378) titled 'Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers' on Sept. 18.
Brief Summary: To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic Diabetic Foot Ulcers.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Diabetic Foot Ulcer (DFU)
Ulcer
Wound Closure
Wound Management
Intervention:
DEVICE: PRFM
Participants will receive weekly applications of PRFM and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever occurs first.
OTHER: Standard...